IPSCs: Unstable origins?

Molecular Therapy

Volumn 19, Issue 7, 2011, Pages 1188-1190

  Mukherjee, Sayandip ^a   Thrasher, Adrian J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR;

CELL DIFFERENTIATION; CHROMOSOME ABERRATION; EMBRYONIC STEM CELL; EPIGENETICS; EVOLUTIONARY ADAPTATION; GENE EXPRESSION REGULATION; GENE INSERTION; GENOMIC INSTABILITY; GENOTOXICITY; HOMOLOGOUS RECOMBINATION; HUMAN; NOTE; ONCOGENE; PLURIPOTENT STEM CELL; TRANSGENE; TRANSPOSON; VIRAL GENE DELIVERY SYSTEM;

EID: 79959948934     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.116     Document Type: Note

References (33)

1. Takahashi, K and Yamanaka, S (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. (Pubitemid 44233629)
2. Yu, J, Vodyanik, MA, Smuga-Otto, K, Antosiewicz-Bourget, J, Frane, JL, Tian, S et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
3. Park, IH, Arora, N, Huo, H, Maherali, N, Ahfeldt, T, Shimamura, A et al. (2008). Disease-specific induced pluripotent stem cells. Cell 134: 877-886.
4. Hanna, J, Wernig, M, Markoulaki, S, Sun, CW, Meissner, A, Cassady, JP et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
5. Raya, A, Rodriguez-Piza, I, Guenechea, G, Vassena, R, Navarro, S, Barrero, MJ et al. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460: 53-59.
6. Naldini, L (2011). Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet 12: 301-315.
7. Mitchell, RS, Beitzel, BF, Schroder, AR, Shinn, P, Chen, H, Berry, CC et al. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234.
8. Winkler, T, Cantilena, A, Metais, JY, Xu, X, Nguyen, AD, Borate, B et al. (2010). No evidence for clonal selection due to lentiviral integration sites in human induced pluripotent stem cells. Stem Cells 28: 687-694.
9. Kane, NM, Nowrouzi, A, Mukherjee, S, Blundell, MP, Greig, JA, Lee, WK et al. (2010). Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors. Mol Ther 18: 2139-2145.
10. Somers, A, Jean, JC, Sommer, CA, Omari, A, Ford, CC, Mills, JA et al. (2010). Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28: 1728-1740.
11. Kustikova, OS, Geiger, H, Li, Z, Brugman, MH, Chambers, SM, Shaw, CA et al. (2007). Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways. Blood 109: 1897-1907. (Pubitemid 46348185)
12. Warren, L, Manos, PD, Ahfeldt, T, Loh, YH, Li, H, Lau, F et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630.
13. Yu, J, Hu, K, Smuga-Otto, K, Tian, S, Stewart, R, Slukvin, II et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
14. Zhou, H, Wu, S, Joo, JY, Zhu, S, Han, DW, Lin, T et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384.
15. Papapetrou, EP, Lee, G, Malani, N, Setty, M, Riviere, I, Tirunagari, LM et al. (2011). Genomic safe harbors permit high beta-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 29: 73-78.
16. Shi, Y, Do, JT, Desponts, C, Hahm, HS, Scholer, HR and Ding, S (2008). A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2: 525-528. (Pubitemid 351729222)
17. Huangfu, D, Maehr, R, Guo, W, Eijkelenboom, A, Snitow, M, Chen, AE et al. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795-797. (Pubitemid 351961456)
18. Nokye-Danso, F, Trivedi, CM, Juhr, D, Gupta, M, Cui, Z, Tian, Y et al. (2011). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8: 376-388.
19. Li, H, Collado, M, Villasante, A, Strati, K, Ortega, S, Canamero, M et al. (2009). The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460: 1136-1139.
20. Hong, H, Takahashi, K, Ichisaka, T, Aoi, T, Kanagawa, O, Nakagawa, M et al. (2009). Suppression of induced pluripotent stem cell generation by the p53?p21 pathway. Nature 460: 1132-1135.
21. Gore, A, Li, Z, Fung, HL, Young, JE, Agarwal, S, Antosiewicz-Bourget, J et al. (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67.
22. Hussein, SM, Batada, NN, Vuoristo, S, Ching, RW, Autio, R, Narva, E et al. (2011). Copy number variation and selection during reprogramming to pluripotency. Nature 471: 58-62.
23. Laurent, LC, Ulitsky, I, Slavin, I, Tran, H, Schork, A, Morey, R et al. (2011). Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8: 106-118.
24. Howden, SE, Gore, A, Li, Z, Fung, HL, Nisler, BS, Nie, J et al. (2011). Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci USA 108: 6537-6542.
25. Draper, JS, Moore, HD, Ruban, LN, Gokhale, PJ and Andrews PW (2004). Culture and characterization of human embryonic stem cells. Stem Cells Dev 13: 325-336. (Pubitemid 39223282)
26. Baker, DE, Harrison, NJ, Maltby, E, Smith, K, Moore, HD, Shaw, PJ et al. (2007). Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 25: 207-215. (Pubitemid 46227120)
27. Mayshar, Y, Ben-David, U, Lavon, N, Biancotti, JC, Yakir, B, Clark, AT et al. (2010). Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7: 521-531.
28. Novak, A, Shtrichman, R, Germanguz, I, Segev, H, Zeevi-Levin, N, Fishman, B et al. (2010). Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus. Cell Reprogram 12: 665-678.
29. Seki, T, Yuasa, S, Oda, M, Egashira, T, Yae, K, Kusumoto, D et al. (2010). Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7: 11-14.
30. Kunisato, A, Wakatsuki, M, Shinba, H, Ota, T, Ishida, I and Nagao, K (2011). Direct generation of induced pluripotent stem cells from human nonmobilized blood. Stem Cells Dev 20: 159-168.
31. Staerk, J, Dawlaty, MM, Gao, Q, Maetzel, D, Hanna, J, Sommer, CA et al. (2010). Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7: 20-24.
32. Loh, YH, Hartung, O, Li, H, Guo, C, Sahalie, JM, Manos, PD et al. (2010). Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7: 15-19.
33. Lister, R, Pelizzola, M, Kida, YS, Hawkins, RD, Nery, JR, Hon, G et al. (2011). Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471: 68-73.